株式会社レトリバ（本社：東京都新宿区、代表取締役 田口琢也）は、かねてよりAI技術をバイオ領域で活用してきました。高速塩基配列検索ソフトウェア 「GGGenome(ゲゲゲノム)※1パッケージ版」 は核酸医薬品の安全性評価において信頼と実績もっています。

Sirna Therapeutics, Inc. has announced that it has signed an exclusive worldwide licensing agreement with the University of Massachusetts Medical School (UMMS) for the rights to patents covering ...

New findings point to an opportunity to improve therapies that use small RNAs to silence disease-causing genes, potentially including those involved in cancer. In everyday life, when things turn out ...

In everyday life, when things turn out the opposite of what you expect, it's usually cause for frustration. In science, it's often the starting point for discovery. That's what happened to a team of ...

New research from Dr. Seungjae Lee (left), Dr. Eric Lai, and their collaborators points to a potential opportunity to improve therapies that use small RNAs to silence disease-causing genes, ...

Abundance of Vehicles Are in Development to Help Translate the Technology into Therapeutics Hailed as the breakthrough of the year in 2002 by Science, RNAi still holds promise as a powerful, novel ...

Researchers from Voyager Therapeutics Inc. presented preclinical activity data of VY-1706, a blood-brain barrier (BBB)-penetrant gene therapy comprising an adeno-associated virus serotype 9 capsid ...